# Gilead Sciences, Inc. (GILD) — Q4-2015 Earnings Results

**Report date:** 2016-02-02 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q4-2015

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.32 | N/A | +14.05% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook regarding their future projects. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management expressed confidence in their product pipeline.

> They highlighted ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Gilead Sciences reported a strong EPS performance, beating expectations by over 14%. However, the lack of revenue data and guidance may leave investors uncertain about future growth. The stock reaction was not available, indicating that market sentiment could be influenced by these uncertainties.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q4-2015_